medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2023; 21 (2)

Trichophyton indotineae: a new challenge in dermatology

García SE, Martínez HE, Acosta AG, Arenas R, Frías LMG
Full text How to cite this article

Language: Spanish
References: 20
Page: 168-172
PDF size: 150.70 Kb.


Key words:

Trichophyton interdigitale, antifungal resistance, glabrous skin, terbinafine.

ABSTRACT

In India, in 2018, Trichophyton indotineae was isolated from a series of severe cases of tinea corpus and/or tinea cruris (skin lesions were extensive, highly inflammatory, sometimes pruritic and with a chronic relapsing course). It was thought that this anthropophilic fungus was endemic to India, and that the cases reported in other countries were imported from Asia; however, there are currently reports of autochthonous cases in different countries such as Germany. T. indotineae has emerged causing concern in the dermatological clinical area, since, although it is not a lethal pathogen, it is easily transmitted from person to person and is usually highly resistant to terbinafine, one of the first-line antifungal treatments of dermatophytosis. Furthermore, since it is phylogenetically related to T. interdigitale and T. mentagrophytes, its identification by conventional phenotypic methods is impossible, therefore molecular methods are required. Dermatologists must be attentive to the presence of T. indotineae to know its local transmission, in order to provide the most appropriate therapeutic management to patients, as well as to further elucidate the epidemiology of this emerging fungus.


REFERENCES

  1. Friedman DZP y Schwartz IS, Emerging fungal infections: newpatients, new patterns, and new pathogens, J Fungi (Basilea) 2019; 5(3):67. Disponible en: https://doi.org/10.3390/jof5030067.

  2. Ghosh A y Panda S, Evidence-based management of dermatophytosisin India today, Apollo Med. Disponible en: https://apollomedicine.org/preprintarticle.asp?id=367276.

  3. Singh A, Masih A, Monroy-Nieto J et al., A unique multidrug-resistantclonal Trichophyton population distinct from Trichophytonmentagrophytes/Trichophyton interdigitale complex causing anongoing alarming dermatophytosis outbreak in India: genomic insightsand resistance profile, Fungal Genet Biol 2019; 133:103266.Disponible en: https://doi.org/10.1016/j.fgb.2019.103266.

  4. Ameen M, Epidemiology of superficial fungal infections, ClinDermatol 2010; 28:197-201. Disponible en: https://doi.org/10.1016/j.clindermatol.2009.12.005.

  5. Kano R, Kimura U, Kakurai M et al., Trichophyton indotineae sp.nov.: a new highly terbinafine-resistant anthropophilic dermatophytespecies, Mycopathologia 2020; 185(6):947-58. Disponibleen: https://doi.org/10.1007/s11046-020-00455-8.

  6. Tang C, Kong X, Ahmed SA et al., Taxonomy of the Trichophytonmentagrophytes/T. interdigitale species complex harboringthe highly virulent, multiresistant genotype T. indotineae, Mycopathologia2021; 186(3):315-26. Disponible en: https://doi.org/10.1007/s11046-021-00544-2.

  7. Jabet A, Brun S, Normand AC et al., Extensive dermatophytosiscaused by terbinafine-resistant Trichophyton indotineae, France,Emerg Infect Dis 2022; 28(1):229-33. Disponible en: https://doi.org/10.3201/eid2801.210883.

  8. Uhrlaß S, Verma SB, Gräser Y et al., Trichophyton indotineae:an emerging pathogen causing recalcitrant dermatophytoses inIndia and worldwide. A multidimensional perspective, J Fungi(Basilea) 2022; 8(7):757. Disponible en: https://doi.org/10.3390/jof8070757.

  9. Chowdhary A, Singh A, Kaur A et al., The emergence and worldwidespread of the species Trichophyton indotineae causing difficult-to-treat dermatophytosis: a new challenge in the managementof dermatophytosis, plos Pathog 2022; 18(9):e1010795.Disponible en: https://doi.org/10.1371/journal.ppat.1010795.

  10. Verma SB, Panda S, Nenoff P et al., The unprecedented epidemic-like scenario of dermatophytosis in India. i. Epidemiology, riskfactors and clinical features, Indian J Dermatol Venereol Leprol2021; 87:154-75. Disponible en: https://doi.org/ 10.25259/IJDVL_301_20.

  11. Nenoff P, Verma SB, Ebert A et al., Spread of terbinafine-resistantTrichophyton mentagrophytes type viii (India) in Germany:“the tip of the iceberg?”, J Fungi (Basilea) 2020; 6: 207. Disponibleen: https://doi.org/ 10.3390/jof6040207.

  12. Dellière S, Joannard B, Benderdouche M et al., Emergence ofdifficult-to-treat tinea corporis caused by Trichophyton mentagrophytescomplex isolates, Paris, France, Emerg InfectDis 2022; 28(1):224-8. Disponible en: https://doi.org/10.3201/eid2801.210810.

  13. Gupta AK, Venkataraman M, Hall DC et al., The emergence ofTrichophyton indotineae: implications for clinical practice, Int JDermatol 2022. Disponible en: https://doi.org/10.1111/ijd.16362.

  14. Posso de los Rios CJ, Tadros E, Summerbell RC et al., Terbinafineresistant Trichophyton indotineae isolated in patientswith superficial dermatophyte infection in Canadian patients, JCutan Med Surg 2022; 26(4):371-6. Disponible en: https://doi.org/10.1177/12034754221077891.

  15. Taghipour S, Shamsizadeh F, Pchelin IM et al., Emergence ofterbinafine resistant Trichophyton mentagrophytes in Iran,harboring mutations in the squalene epoxidase (sqle) gene,Infect Drug Resist 2020; 13:845-50. Disponible en: https://doi.org/10.2147/IDR.S246025.

  16. Normand AC, Moreno-Sabater A, Jabet A et al., maldi-tof massspectrometry online identification of Trichophyton indotineaeusing the msi-2 application, J Fungi (Basilea) 2022; 8:1103. Disponibleen: https://doi.org/10.3390/ jof8101103.

  17. Batvandi A, Pchelin IM, Kiasat N et al., Time and cost-efficientidentification of Trichophyton indotineae, Mycoses 2023;66(1):75–81. Disponible en: https://doi.org/10.1111/myc.13530.

  18. Moreno-Sabater A, Normand AC, Bidaud AL et al., Terbinafineresistance in dermatophytes: a French multicenter prospectivestudy, J Fungi (Basilea) 2022; 8(3):220. Disponible en: https://doi.org/10.3390/jof8030220.

  19. Gawaz A, Nenoff P, Uhrlaß S et al., Treatment of a terbinafineresistantTrichophyton mentagrophytes type viii, Hautarzt 2021;72:900-4. Disponible en: https://doi.org/10.1007/s00105-021-04857-7.

  20. Singh S, Chandra U, Anchan VN et al., Limited effectiveness offour oral antifungal drugs (fluconazole, griseofulvin, itraconazoleand terbinafine) in the current epidemic of altered dermatophytosisin India: results of a randomized pragmatic trial, Br J Dermatol2020; 183:840-6. Disponible en: https://doi.org/10.1111/bjd.19146.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2023;21